Related Experiment Video

Updated: Aug 26, 2026

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

Gene and immune therapy for renal cell carcinoma

A J Pantuck1, A Zisman, A Belldegrun

  • 1Division of Urologic Oncology, Department of Urology, University of California School of Medicine, Los Angeles, California, USA. apantuck@mednet.ucla.edu

International Journal of Urology : Official Journal of the Japanese Urological Association
|July 10, 2001
PubMed

Insights

Metastatic renal cell carcinoma has limited treatment options. Cancer immunotherapy and gene therapy offer novel approaches by harnessing the immune system to fight cancer.

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • Conventional treatments for metastatic renal cell carcinoma (RCC) demonstrate poor efficacy and limited long-term survival.
  • Observations of spontaneous tumor regression and delayed metastasis in some patients suggest a role for host immune responses against cancer.
  • Advances in molecular gene transfer and understanding immune activation pathways have spurred the development of novel cancer immunotherapies.

Purpose of the Study:

  • To present current immunotherapy and gene therapy strategies for metastatic renal cell carcinoma.
  • To highlight novel approaches for leveraging the immune system in cancer treatment.

Main Methods:

  • Review of current immunotherapy strategies.
  • Discussion of gene therapy techniques for cancer treatment.
  • Presentation of cytokine delivery methods.
  • Overview of tumor-cell-based vaccine approaches.

Main Results:

  • Immunotherapy and gene therapy represent promising avenues for treating metastatic renal cell carcinoma.
  • Novel strategies are being developed to harness the patient's immune system against cancer cells.

Conclusions:

  • Cancer immunotherapy and gene therapy offer new hope for patients with metastatic renal cell carcinoma.
  • Harnessing the immune system is a key strategy in developing effective cancer treatments.

More Related Videos

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies06:38

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

Published on: April 12, 2017

Effective and Safe Gene Delivery to the Mouse Kidney via Slow Retrograde Renal Pelvis Injection of Adeno-Associated Virus Vectors06:24

Effective and Safe Gene Delivery to the Mouse Kidney via Slow Retrograde Renal Pelvis Injection of Adeno-Associated Virus Vectors

Published on: August 1, 2025

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.